Perspective: Progress on the study and treatment of depressive illness

Neuropsychopharmacology

Volumn 34, Issue 6, 2009, Pages 1361-1362

  Carlezon, William A ^a   Chartoff, Elena ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; CORTICOTROPIN RELEASING FACTOR; HALOPERIDOL; MICRORNA; MOOD STABILIZER; PSYCHOTROPIC AGENT;

DEPRESSION; ENVIRONMENTAL FACTOR; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT SURVEY; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HUMANS; PERIODICALS AS TOPIC; PSYCHOTROPIC DRUGS;

EID: 64949108078     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.16     Document Type: Short Survey

References (9)

1. Bosch OJ, Nair HP, Ahern TH, Neumann ID, Young LJ (2009). The CRF system mediates increased passive stress-coping behavior following the loss of a bonded partner in a monogamous rodent. Neuropsychopharmacol, in press.
2. Keller MC, Neale MC, Kendler KS (2007). Association of different adverse life events with distinct patterns of depressive symptoms. Am J Psychiatry 164: 1521-1529.
3. Krebs HA (1975). The August Krogh principle: 'For many problems there is an animal on which it can be most conveniently studied. J Exp Zoology 194: 221-226.
4. Law AJ, Pei Q, Walker M, Gordon-Andrews H, Weickert CS, Feldon J et al (2009). Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder. Neuropsychopharmacol, in press.
5. Meltzer HY (1988). New insights into schizophrenia through atypical antipsychotic drugs. Neuropsychopharmacol 1: 193-196.
6. Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G et al (2009). Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacol, in press.
7. Simson PE, Weiss JM (1988). Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacol 1: 287-295.
8. Todorovic C, Sherrin T, Pitts M, Hippel C, Rayner M, Spiess J (2009). Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF(2)-deficient mice. Neuropsychopharmacol, in press.
9. Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y et al (2009). Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacol, in press.